Page last updated: 2024-08-24

adefovir dipivoxil and Lymphoma, Non-Hodgkin

adefovir dipivoxil has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Enomoto, M; Hino, M; Nishiguchi, S; Seki, S; Yamane, T1

Other Studies

1 other study(ies) available for adefovir dipivoxil and Lymphoma, Non-Hodgkin

ArticleYear
Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:8

    Topics: Adenine; Adult; Antiviral Agents; Carrier State; Drug Resistance; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Organophosphonates; Reverse Transcriptase Inhibitors

2004